Addressing Neuropsychiatric Symptoms in Huntington Disease: Expert Interview
Depression is the most frequently observed psychiatric disorder in HD, with an estimated prevalence of 40% to 50%.
MOVEMENT DISORDERS ADVISOR
Movement Disorders Advisor
Features
-
-
Functional Imaging in Movement Disorders: Diagnostic Advantages
Functional imaging can help neurologists navigate diagnosis and inform treatment and patient outcomes. -
Addressing Levodopa-Resistant Parkinson Disease
In later stages of the condition, it is possible that the nerves become incapable of storing dopamine consistently, rendering levodopa practically useless, even if it is administered more regularly. -
Managing Complications of Intrathecal Baclofen Therapy
Facilities with strict protocols to prevent problems have been able to report significantly lower complication rates. -
Parkinson Disease and the Gut: Treatment Potential Abounds
Current evidence highlights the potential role of cross-talk between the enteric and central nervous systems and the pathogenesis of Parkinson disease.
News
Cerebrospinal Fluid β-amyloid 1-42 Predicts Freezing of Gait in Early Parkinson Disease
White Matter Regions Localized to Distinct Pathways in Essential Tremor
High Plasma NFL Linked to Poor Cognition in Alzheimer and Parkinson Disease
Dopaminergic-Driven Hyperalgesia Contributes to Parkinson Disease Pain
Journal Articles
Oosterwijk CS, Vriend C, Berendse HW, van der Werf YD, van den Heuvel OA. Anxiety in Parkinson’s disease is associated with reduced structural covariance of the striatum.
J Affect Disord. 2018;240:113-120.
J Affect Disord. 2018;240:113-120.
Gilbert DL, Murphy TK, Jankovic J, et al. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study
[published online September 7, 2018]. Mov Disord. doi: 10.1002/mds.27457
[published online September 7, 2018]. Mov Disord. doi: 10.1002/mds.27457
Rozani V, Gurevich T, Giladi N, et al. Higher serum cholesterol and decreased Parkinson’s disease risk: A statin-free cohort study
[published online August 25, 2018]. Mov Disord. doi: 10.1002/mds.27413
[published online August 25, 2018]. Mov Disord. doi: 10.1002/mds.27413
Katz M, Goto Y, Kluger BM, et al. Top ten tips palliative care clinicians should know about Parkinson’s disease and related disorders
[published online September 11, 2018]. J Palliat Med. doi: 10.1089/jpm.2018.0390
[published online September 11, 2018]. J Palliat Med. doi: 10.1089/jpm.2018.0390
Martinez-Martin P, Kulisevsky J, Mir P, Tolosa E, García-Delgado P, Luquin MR. Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire.
NPJ Parkinsons Dis. 2018; 4:20.
NPJ Parkinsons Dis. 2018; 4:20.
Ferrazzoli D, Ortelli P, Zivi I, et al. Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: randomised controlled study
[published online January 10, 2018]. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2017-316437
[published online January 10, 2018]. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2017-316437
Patient Education Materials
Huntington’s Disease: Essential Facts for Patients
Essential Tremor: Essential Facts for Patients
Tics and Tourette Syndrome: Essential Facts for Patients
Impulse Control Disorders In Parkinson’s Disease: Essential Facts for Patients
Deep Brain Stimulation for Parkinson’s Disease: Essential Facts for Patients
Dystonia: Essential Facts for Patients
Essential Tremor: Essential Facts for Patients
Tics and Tourette Syndrome: Essential Facts for Patients
Impulse Control Disorders In Parkinson’s Disease: Essential Facts for Patients
Deep Brain Stimulation for Parkinson’s Disease: Essential Facts for Patients
Dystonia: Essential Facts for Patients
Want to read more?
Please login or register first to view this content.
Next post in Movement Disorders Advisor
